Advertisement

Topics

Syapse raises a $30M Series D round to scale its precision medicine program

08:45 EST 14 Nov 2017 | MedCity News

dollar, money, funds, cash

Life science companies recognize that they need to be able to work more closely with providers,” said CEO Ken Tarkoff.

Original Article: Syapse raises a $30M Series D round to scale its precision medicine program

NEXT ARTICLE

More From BioPortfolio on "Syapse raises a $30M Series D round to scale its precision medicine program"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Bioscience
Bioscience - any of the sciences that deal with living organisms.  The study of the nature, behavior, and uses of living organisms as applied to biology. Any of the branches of natural science dealing with living things, such as their structure, b...